3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
48
Myelodysplastic Syndromes
23
Leukemia, Myelomonocytic, Chronic
10
Leukemia
7
Recurrence
6
Ovarian Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Primary Myelofibrosis
2
Neoplasms
2
Myeloproliferative Disorders
2
Melanoma
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma, Synovial
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Older Patients
1
Myeloid Malignancies
1
Interventions
Specimen Handling
3
Biopsy
3
Azacitidine
2
venetoclax
1
veliparib
1
ruxolitinib
1
pevonedistat
1
peginterferon alfa-2b
1
onvansertib
1
fludarabine phosphate
1
axatilimab
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation Conditioning
1
Topotecan
1
Therapeutics
1
Tacrolimus
1
Sirolimus
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Hyperbaric Oxygenation
1
High-Energy Shock Waves
1
Geriatric Assessment
1
Ganciclovir
1
Foscarnet
1
Flow Cytometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Decitabine
×
1 year
×
Clear all
No trials found.